D89.839
Cytokine release syndrome, grade unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytokine release syndrome (CRS), also known as cytokine storm, is a condition that occurs when the immune system releases a large amount of cytokines into the bloodstream. Cytokines are proteins that help regulate the immune response, but when released in excess, they can cause widespread inflammation and damage to tissues and organs. The grade unspecified designation indicates that the severity of the syndrome has not been classified into specific categories, emphasizing the importance of medical assessment and management. While CRS can be triggered by certain medical treatments or infections, understanding its mechanisms and symptoms is crucial for timely intervention.
Causes & Symptoms
Clinical Causes: Certain cancer immunotherapies, such as CAR T-cell therapy Infections, especially viral infections like COVID-19 In some cases, autoimmune conditions Other immune-modulating treatments
Key Symptoms: High fever that develops quickly Tiredness and fatigue Muscle aches and joint pain Nausea and vomiting Low blood pressure leading to dizziness or fainting Difficulty breathing or shortness of breath Swelling due to fluid retention Rash or skin redness Altered mental state, confusion or agitation
Diagnostic & Treatment
Diagnosis Path: Diagnosing cytokine release syndrome involves a combination of clinical evaluation and laboratory tests. Healthcare providers assess symptoms, especially the timing and severity, in conjunction with blood tests that may reveal elevated levels of cytokines, inflammation markers like C-reactive protein (CRP) and ferritin, and signs of organ dysfunction. Imaging studies may be performed if organ involvement is suspected. The specific grading and assessment are crucial for guiding treatment strategies.
Treatment Protocols: Management of CRS depends on its severity and underlying cause. Common approaches include: - Supportive care such as intravenous fluids, oxygen therapy, and medications to manage fever and pain. - Use of corticosteroids to reduce inflammation. - Administration of cytokine inhibitors like tocilizumab to block specific cytokines involved in the storm. - Monitoring and treating organ dysfunction as needed. - In severe cases, intensive care support may be required. Medical teams tailor treatments based on individual patient needs to control immune response and prevent complications.
Clinical Advice & FAQs
Billing Guidance
Is D89.839 a billable ICD-10 code?
Yes, D89.839 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.839?
Clinical documentation must specify the nature of Cytokine release syndrome, grade unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference